HCW Biologics Inc. 8-K

What Happened
HCW Biologics Inc. (HCW Biologics) filed an 8-K (Item 8.01) saying it will report a settlement and extinguishment of $2.8 million of disputed accounts payable in the quarter ended June 30, 2026. On June 26, 2026, HCW received notice that B&I Contractors, Inc. filed a Voluntary Dismissal with Prejudice, dismissing B&I’s crossclaims in BE&K Building Group, LLC v. HCW Biologics Inc., et al., and filed a final Satisfaction of Lien removing a $1.1 million lien on HCW’s property at 3300 Corporate Way, Miramar, Florida. Separately, under a December 9, 2025 settlement with contract manufacturer EirGenix, Inc., HCW paid the agreed amounts (a $620,000 payment on March 3, 2026 and another $620,000 on May 26, 2026) and stated its obligations to EirGenix were paid in full on May 26, 2026.

Key Details

• The company will report a $2.8 million settlement and extinguishment of disputed accounts payable for the quarter ended June 30, 2026.
• June 26, 2026: B&I filed a Voluntary Dismissal with Prejudice and a Satisfaction of Lien removing a $1.1M mechanics’ lien tied to renovations at 3300 Corporate Way (Miramar, FL).
• EirGenix settlement (agreement dated Dec 9, 2025): originally claimed amounts reduced from $1.7M to $1.2M if paid by agreed date; HCW made payments of $620,000 on Mar 3, 2026 and $620,000 on May 26, 2026 and reports the obligation was paid in full on May 26, 2026.
• Filing is reported under Item 8.01 (Other Events) and includes forward-looking statement cautionary language.

Why It Matters
These settlements remove disputed liabilities and a recorded lien, which will affect HCW Biologics’ reported liabilities and could impact the company’s results and balance sheet for the quarter ended June 30, 2026. For investors, the resolution of these disputes reduces uncertainty tied to outstanding claims and property encumbrances; the company’s 8-K also notes forward-looking statements and directs readers to its SEC filings (e.g., Form 10-K and 10-Qs) for risk factors and further context.